Biologically active peptide derived from frog (frog CNP)

Details Biologically active peptide derived from frog (frog CNP) Biologically active peptide derived from frog (frog CNP)

1991-09-04

1994-08-09

Cashion, Jr., Merrell C.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

15 to 23 amino acid residues in defined sequence

C07K 700, A61K 3702

Patent

active

053367596

ABSTRACT:
A novel peptide that exhibits a natriuretic action and a vasodepressor activity, and hence, that is applicable for a diagnostic reagent. The novel peptide is manufactured by tile procedure of genetic engineering as well as by the methods of purification from frog brains or by chemical synthesis.

REFERENCES:
patent: 4904763 (1990-02-01), Matsuo et al.
patent: 5114923 (1992-05-01), Seilhamer et al.
Yoshihara et al. Biochem. Biophys. Res. Commun. (1990) 173(2) 591-8.
Minamino et al. Pept. Chem. (1991) 28 367-72.
Yoshihara et al, "Chemical Abstracts", Columbus, Apr. 1, 1991, vol. 114, No. 13; Minamino et al, Chemical Abstracts, Columbus, Aug. 19, 1991, vol. 115 No. 7; Nakao et al, Chemical Abstracts, Columbus, Nov. 19, 1990, vol. 113 No. 21.
Minamino et al; C-Type Natriuretic Peptide (CNP); Biochemical and Biophysical Research Communications; vol. 168, No. 2, 1990.
Minamino et al.; N-Terminally Extended Form of C-Type Natriuretic Peptide (DNP-53) Identified in Porcine Brain; vol. 170, No. 2, 1990.

Affiliated with

Also associated with

Rating

Biologically active peptide derived from frog (frog CNP) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active peptide derived from frog (frog CNP), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active peptide derived from frog (frog CNP) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-216762